Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer

NCT03661567 PHASE2 TERMINATED

This Phase II randomized controlled study is to determine the efficacy of the preventively use of methylprednisolone after split-course chemoradiotherapy (CCRT) in locally advanced non-small cell lung cancer with bulky tumor.

Details

Lead sponsor	Sun Yat-sen University
Phase	PHASE2
Status	TERMINATED
Enrolment	52
Start date	Thu Aug 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Sep 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Non-small Cell Lung Cancer

Interventions

• chest radiation
• concurrent chemotherapy
• Methylprednisolone

Countries

China